Cover Image: August 2012 Scientific American Magazine See Inside

Could Bacteria-Fighting Viruses Replace Overused Antibiotics? [Preview]

Long ignored by mainstream researchers, the viruses that infect bacteria have a role to play in modern medicine, Vincent Fischetti says















Share on Tumblr



Image: Spencer Heyfron

In Brief

  • WHO
    Vincent Fischetti
  • VOCATION | AVOCATION
    Microbiologist
  • WHERE
    Rockefeller University
  • RESEARCH FOCUS
    Finding an alternative to overused antibiotics.
  • BIG PICTURE
    Could viruses that attack bacteria be used to treat and prevent infections?

 

More In This Article

Inside a third-floor office a few blocks from the Hudson River in Yonkers, N.Y., a small biotechnology company called ContraFect prepares to test a remarkable new way to kill bacteria in humans. Antibiotics, after many years of use and overuse, have lost their edge against rapidly evolving bacteria, with everything from staph infections to tuberculosis becoming more devastating, deadly and difficult to treat. Whereas traditional antibiotics have mostly been derived from chemicals produced by soil bacteria and fungi, ContraFect has found an alternative in bacteriophages: viruses that infect bacteria and hijack their internal machinery. In nature, phages produce enzymes called lysins, causing the bacteria fall to pieces and new phages to tumble out by the hundreds. ContraFect believes it can harness these lysins to treat bacterial infections in humans.

The first trials for patient safety are expected to start this year. It is a moment that Vincent Fischetti, a 71-year-old microbiologist at the Rockefeller University, has been approaching for decades. A child of working-class parents on Long Island, he once thought he would be a dentist before getting hooked on microbiology as an undergraduate. Studying for his master's degree by night and paying his bills as a technician on a scarlet fever project by day, he became fascinated by phages. After years of work, he demonstrated, in 2001, that lysins could help mice fight strep throat infection. The military also sees potential in lysins, which could be administered before surgery to prevent infection or spread over surfaces to clean an area contaminated by an anthrax attack.


This article was originally published with the title Phage Factor.



Subscribe     Buy This Issue

Already a Digital subscriber? Sign-in Now
If your institution has site license access, enter here.
Rights & Permissions

5 Comments

Add Comment
View
  1. 1. Mythusmage 11:09 PM 8/1/12

    I can see the headline a century from now, "Could Antibiotics Replace Overused Bacteria-Fighting Viruses?"

    Reply | Report Abuse | Link to this
  2. 2. Richieo 09:38 AM 8/7/12

    Bacteriophage Is this something new?

    They have been used for over 90 years as an alternative to antibiotics in the former Soviet Union and Eastern Europe, as well as in France.
    They are seen as a possible therapy against multi-drug-resistant strains of many bacteria. (from Wiki)

    Are we playing catch-up again?

    Reply | Report Abuse | Link to this
  3. 3. whiterabbit1990 07:50 AM 8/8/12

    Didn't they watch 'I am Legend'? :(

    Reply | Report Abuse | Link to this
  4. 4. jimfromcanada in reply to Richieo 02:07 AM 8/14/12

    I agree the Russians have been far ahead of the west in this technology. In fact the collapse of the Soviet Union caused the closing down of support for this technology. It was then taken up by western pharmaceuticals and here is the result we see. It would be nice to see some credit given to the Russian scientists who have developed this technology, even if their government abandoned them and it.

    Reply | Report Abuse | Link to this
  5. 5. Acoyauh2 06:53 PM 9/3/12

    Interesting...
    These guys are experimenting not with the actual phages, but with the protein phages use to lyse the bacteria.
    Russian usage involves identifying the right phage and unleashing the actual virus against the infecting bugs. Odds are, using phages means keeping up with the bugs, since phages would necessarily evolve with their prey.
    Misuse/overuse of the phage protein(s) alone means sooner or later the bugs will be resilient to them.

    whiterabbit1990: While injecting live viruses as medicine does bring to mind 'I am Legend' and its likes, phages are so specialized they'll hardly switch species, let alone switch from bacteria to - ahem - people as prey. You're not lost, though. Once this therapy is developed and starts paying off, we'll start playing with cancer-eating phages (the concept has been thrown about plenty already) and THEN we should worry. A virus can easily switch from sick to healthy cells as prey, and then not even Mila Jojovich will be able to save our 'hinds
    So there is still hope for a Zombie Apocalypse of some sort; just give virologists enough time =)

    Reply | Report Abuse | Link to this
Leave this field empty

Add a Comment

You must sign in or register as a ScientificAmerican.com member to submit a comment.
Click one of the buttons below to register using an existing Social Account.

More from Scientific American

See what we're tweeting about

Scientific American Editors

More »

Free Newsletters


Get the best from Scientific American in your inbox

Solve Innovation Challenges

Powered By: Innocentive

  SA Digital
  SA Digital

Email this Article

Could Bacteria-Fighting Viruses Replace Overused Antibiotics?: Scientific American Magazine

X
Scientific American Magazine

Subscribe Today

Save 66% off the cover price and get a free gift!

Learn More >>

X

Please Log In

Forgot: Password

X

Account Linking

Welcome, . Do you have an existing ScientificAmerican.com account?

Yes, please link my existing account with for quick, secure access.



Forgot Password?

No, I would like to create a new account with my profile information.

Create Account
X

Report Abuse

Are you sure?

X

Institutional Access

It has been identified that the institution you are trying to access this article from has institutional site license access to Scientific American on nature.com. To access this article in its entirety through site license access, click below.

Site license access
X

Error

X

Share this Article

X